U.S. Sex Reassignment Surgery Market Size, Share & Trends Analysis Report By Gender Transition (Female-to-male, Male-to-female), By Procedure (Mastectomy, Vaginoplasty, Scrotoplasty, Hysterectomy, Phalloplasty), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation
                   1.2. Estimates and Forecast Timeline
                   1.3. Research Methodology
                       1.3.1. Information procurement
                       1.3.2. Purchased Database
                       1.3.3. GVR’s Internal Database
                       1.3.4. Secondary Sources
                       1.3.5. Primary Research
                       1.3.6. Details of Primary Research
                   1.4. Information or Data Analysis
                       1.4.1. Data Analysis Models
                   1.5. 1.5 Market Formulation & Validation
                       1.5.1. Volume Price Analysis
                   1.6. List of Secondary Sources
                   1.7. List of Abbreviations
                   1.8. Research Objectives
                       1.8.1. Objective - 1
                       1.8.2. Objective - 2
                       1.8.3. Objective - 3
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                   3.1. Market Dynamics
                       3.1.1. Market Driver Analysis
                           3.1.1.1. Increasing prevalence of gender dysphoria
                           3.1.1.2. Improving reimbursement scenario and Government aids
                           3.1.1.3. Increasing public awareness about transgender surgeries
                           3.1.1.4. Increasing novel hormonal therapies with better efficacy
                       3.1.2. Market Restraint Analysis
                           3.1.2.1. High cost of procedures
                           3.1.2.2. Risks associated with surgical procedures
                   3.2. Industry Analysis Tools
                       3.2.1. Porter’s Five Forces Analysis
                       3.2.2. PESTLE Analysis
                   3.3. Regulatory Framework & Reimbursement Scenario
                   3.4. Target Population Analysis
                   3.5. Patient Journey Analysis Based on a Hypothetical Case Study
                   3.6. COVID-19 Impact Analysis
Chapter 4. U.S. Sex Reassignment Surgery Market: Gender Transition Estimates & Trend Analysis
                   4.1. Segment Definitions
                   4.2. U.S. Sex Reassignment Surgery Market: Segment Dashboard
                   4.3. U.S. Sex Reassignment Surgery Market: Gender Transition Movement & Market Share Analysis
                   4.4. Male-to-Female
                       4.4.1. Male-to-Female Market, 2018 - 2030 (USD Million)
                   4.5. Female-to-Male
                       4.5.1. Female-to-Male Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Sex Reassignment Surgery Market: Procedure Estimates & Trend Analysis
                   5.1. Segment Definitions
                   5.2. U.S. Sex Reassignment Surgery Market: Segment Dashboard
                   5.3. U.S. Sex Reassignment Surgery Market: Region Movement & Market Share Analysis
                   5.4. Augmentation Mammoplasty
                       5.4.1. Augmentation Mammoplasty Market, 2018 - 2030 (USD Million)
                   5.5. Voice Feminization Surgery
                       5.5.1. Voice Feminization Surgery Market, 2018 - 2030 (USD Million)
                   5.6. Reduction Thyrochondroplasty
                       5.6.1. Reduction Thyrochondroplasty Market, 2018 - 2030 (USD Million)
                   5.7. Orchiectomy
                       5.7.1. Orchiectomy Market, 2018 - 2030 (USD Million)
                   5.8. Vaginoplasty
                       5.8.1. Vaginoplasty Market, 2018 - 2030 (USD Million)
                   5.9. Chest Masculinization Surgery
                       5.9.1. Chest Masculinization Surgery Market, 2018 - 2030 (USD Million)
                   5.10. Scrotoplasty
                       5.10.1. Scrotoplasty Market, 2018 - 2030 (USD Million)
                   5.11. Hysterectomy
                       5.11.1. Hysterectomy Market, 2018 - 2030 (USD Million)
                   5.12. Phalloplasty
                       5.12.1. Phalloplasty Market, 2018 - 2030 (USD Million)
                   5.13. Mastectomy
                       5.13.1. Mastectomy Market, 2018 - 2030 (USD Million)
                   5.14. Metoidioplasty
                       5.14.1. Metoidioplasty Market, 2018 - 2030 (USD Million)
                   5.15. Facial Feminization Surgery
                       5.15.1. Facial Feminization Surgery Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
                   6.1. Company Profiles
                       6.1.1. Icahn School of Medicine at Mount Sinai
                           6.1.1.1. Overview
                           6.1.1.2. Financial Performance
                           6.1.1.3. Service Benchmarking
                           6.1.1.4. Strategic Initiatives
                       6.1.2. Transgender Surgery Institute
                           6.1.2.1. Overview
                           6.1.2.2. Financial Performance
                           6.1.2.3. Service Benchmarking
                           6.1.2.4. Strategic Initiatives
                       6.1.3. Cedars-Sinai
                           6.1.3.1. Overview
                           6.1.3.2. Financial Performance
                           6.1.3.3. Service Benchmarking
                           6.1.3.4. Strategic Initiatives
                       6.1.4. Moein Surgical Arts
                           6.1.4.1. Overview
                           6.1.4.2. Financial Performance
                           6.1.4.3. Service Benchmarking
                           6.1.4.4. Strategic Initiatives
                       6.1.5. Cleveland Clinic
                           6.1.5.1. Overview
                           6.1.5.2. Financial Performance
                           6.1.5.3. Service Benchmarking
                           6.1.5.4. Strategic Initiatives
                       6.1.6. CNY Cosmetic & Reconstructive Surgery
                           6.1.6.1. Overview
                           6.1.6.2. Financial Performance
                           6.1.6.3. Service Benchmarking
                           6.1.6.4. Strategic Initiatives
                       6.1.7. Plastic Surgery Group of Rochester
                           6.1.7.1. Overview
                           6.1.7.2. Financial Performance
                           6.1.7.3. Service Benchmarking
                           6.1.7.4. Strategic Initiatives
                       6.1.8. Regents of the University of Michigan
                           6.1.8.1. Overview
                           6.1.8.2. Financial Performance
                           6.1.8.3. Service Benchmarking
                           6.1.8.4. Strategic Initiatives
                       6.1.9. Boston Medical Center
                           6.1.9.1. Overview
                           6.1.9.2. Financial Performance
                           6.1.9.3. Service Benchmarking
                           6.1.9.4. Strategic Initiatives
                       6.1.10. The Johns Hopkins University
                           6.1.10.1. Overview
                           6.1.10.2. Financial Performance
                           6.1.10.3. Service Benchmarking
                           6.1.10.4. Strategic Initiatives
                       6.1.11. Kaiser Permanente
                           6.1.11.1. Overview
                           6.1.11.2. Financial Performance
                           6.1.11.3. Service Benchmarking
                           6.1.11.4. Strategic Initiatives
                       6.1.12. University of California, San Francisco Center of Excellence for Transgender Health
                           6.1.12.1. Overview
                           6.1.12.2. Financial Performance
                           6.1.12.3. Service Benchmarking
                           6.1.12.4. Strategic Initiatives
                       6.1.13. New York Presbyterian Hospital
                           6.1.13.1. Overview
                           6.1.13.2. Financial Performance
                           6.1.13.3. Service Benchmarking
                           6.1.13.4. Strategic Initiatives
                       6.1.14. Mayo Clinic (Transgender and Intersex Specialty Care Clinic)
                           6.1.14.1. Overview
                           6.1.14.2. Financial Performance
                           6.1.14.3. Service Benchmarking
                           6.1.14.4. Strategic Initiatives
                   6.2. Company Categorization
                   6.3. Company Market Position Analysis
                   6.4. Strategy Mapping
Chapter 7. Recommendations/Key Market Insights

List of Tables

Table 1 U.S. Sex Reassignment Surgery Market, by Gender Transition, 2018 - 2030 (USD Million)
Table 2 U.S. Sex Reassignment Surgery Market, by Procedure, 2018 - 2030 (USD Million)
Table 3 List of secondary sources
Table 4 List of abbreviations
Table 5 Medicaid enrollment of transgender adults, by state
Table 6 Medicaid enrollment of transgender adults, by state
Table 7 Cost of Procedure

List of Figures

Fig. 1 U.S. sex reassignment surgery market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Information procurement
Fig. 5 Primary research pattern
Fig. 6 Market research approaches
Fig. 7 Value chain-based sizing & forecasting
Fig. 8 QFD modeling for market share assessment
Fig. 9 Market formulation & validation
Fig. 10 Market snapshot, 2022
Fig. 11 Segment outlook
Fig. 12 Competitive landscape
Fig. 13 U.S. sex reassignment surgery market dynamics
Fig. 14 U.S. sex reassignment surgery market: PESTLE analysis
Fig. 15 U.S. sex reassignment surgery market: Porter’s five forces analysis
Fig. 16 U.S sex reassignment surgery ownership market: Segment dashboard
Fig. 17 U.S. sex reassignment surgery market: Gender transition movement & market share analysis
Fig. 18 Male-to-female transition surgery, 2018 - 2030 (USD Million)
Fig. 19 Female-to-male transition surgery, 2018 - 2030 (USD Million)
Fig. 20 U.S sex reassignment surgery procedure market: Segment dashboard
Fig. 21 U.S. sex reassignment surgery market: Procedure movement & market share analysis
Fig. 22 Augmentation mammoplasty market, 2018 - 2030 (USD Million)
Fig. 23 Voice feminization surgery market, 2018 - 2030 (USD Million)
Fig. 24 Orchiectomy market, 2018 - 2030 (USD Million)
Fig. 25 Vaginoplasty market, 2018 - 2030 (USD Million)
Fig. 26 Chest masculinization surgery market, 2018 - 2030 (USD Million)
Fig. 27 Scrotoplasty market, 2018 - 2030 (USD Million)
Fig. 28 Hysterectomy market, 2018 - 2030 (USD Million)
Fig. 29 Phalloplasty market, 2018 - 2030 (USD Million)
Fig. 30 Mastectomies market, 2018 - 2030 (USD Million)
Fig. 31 Metoidioplasty market, 2018 - 2030 (USD Million)
Fig. 32 Facial feminization surgery market, 2018 - 2030 (USD Million)
Fig. 33 Reduction thyrochondroplasty market, 2018 - 2030 (USD Million)
Fig. 34 Company/competition categorization
Fig. 35 Company market position analysis
Fig. 36 Strategy mapping